Abstract
We investigated the feasibility of a new deep-learning (DL)-based lung analysis method for the evaluation of interstitial lung disease (ILD) by comparing it with evaluation using the traditional computer-aided diagnosis (CAD) system and patients’ clinical outcomes. We prospectively included 104 patients (84 with and 20 without ILD). An expert radiologist defined regions of interest in the typical areas of normal, ground-glass opacity, consolidation, consolidation with fibrosis (traction bronchiectasis), honeycombing, reticulation, traction bronchiectasis, and emphysema, and compared them with the CAD and DL-based analysis results. Next, we measured the extent of ILD lesions with the CAD and DL-based analysis and compared them. Finally, we compared the lesion extent on computed tomography (CT) images, as measured with the DL-based analysis, with pulmonary function tests results and patients’ overall survival. Pearson’s correlation analysis revealed a significant correlation between DL-based analysis and CAD results. Forced vital capacity was significantly correlated with DL-based analysis (r = 0.789, p < 0.001 for normal lung volume and r = −0.316, p = 0.001 for consolidation with fibrosis volume). Consolidation with fibrosis measured using DL-based analysis was independently associated with poor survival. The lesion extent measured using DL-based analysis showed a negative correlation with the pulmonary function test results and prognosis.
Reference31 articles.
1. Spectrum of Fibrotic Lung Diseases;Wijsenbeek;N. Engl. J. Med.,2020
2. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline;Raghu;Am. J. Respir. Crit. Care Med.,2022
3. Quantitative CT Analysis of Diffuse Lung Disease;Chen;Radio Graph.,2019
4. Yang, C.-C., Chen, C.-Y., Kuo, Y.-T., Ko, C.-C., Wu, W.-J., Liang, C.-H., Yun, C.-H., and Huang, W.-M. (2022). Radiomics for the Prediction of Response to Antifibrotic Treatment in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study. Diagnostics, 12.
5. Risoli, C., Nicolò, M., Colombi, D., Moia, M., Rapacioli, F., Anselmi, P., Michieletti, E., Ambrosini, R., Di Terlizzi, M., and Grazioli, L. (2022). Different Lung Parenchyma Quantification Using Dissimilar Segmentation Software: A Multi-Center Study for COVID-19 Patients. Diagnostics, 12.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献